CGT-focused CDMOs are transforming biomanufacturing by addressing the unique challenges of cell and gene therapy production. Their specialized capabilities support process development, quality control, regulatory readiness, and scalable manufacturing, allowing biotech innovators to focus on research while ensuring reliable, compliant, and efficient delivery of advanced therapeutic pro... https://xelleratherapeutic.wixsite.com/xellera-therapeutics/post/why-cgt-focused-cdmos-are-the-future-of-biomanufacturing